We turn the microphone around once again and get the opportunity to learn more about our host, Karen Brown. Listen as Karen discusses her most recent involvement in the Pathways to Health Equity symposium at the University of Montana, the importance of bringing clinical trials to rural and tribal communities, and the current initiatives happening to diversify research populations. To learn more about Karen or KLEO Research, visit https://www.kleoresearch.com/

Dawn Fallon is an award-winning public relations professional with over 25 years of experience, leading a variety of integrated campaigns and educational awareness programs for medical device, biotech, and pharma companies. After nearly 30 years with PR firms, supporting clients including J&J, Medtronic, Pfizer, and CVS. She's launching her own firm, New Dawn Communications. To learn more about Dawn and New Dawn Communications, please visit https://newdawncomms.com/

Today we are speaking with Rose Weinstein, Vice President of Clinical Affairs at Moximed. Rose has her hands full preparing for post-market clinical studies after Moximed brought their implantable shock absorber, the MISHA™ Knee System, to market in April 2023. Prior to joining Moximed in 2018, Rose spent over 5 years as a clinical research associate before joining NeoTract as a manager of clinical affairs. Listen as Rose explains why data-driven decisions are the future of medical breakthroughs and how they shape the path to excellence in clinical research. From the power of patient stories to the significance of post-market studies, this episode offers a comprehensive view of the clinical research journey.